Xenazine FDA Approval History
FDA Approved: Yes (First approved August 15, 2008)
Brand name: Xenazine
Generic name: tetrabenazine
Company: Prestwick Pharmaceuticals, Inc.
Treatment for: Huntington’s Chorea
Xenazine (tetrabenazine) is a selective and reversible centrally-acting dopamine depleting drug indicated for the treatment of chorea associated with Huntington's disease.
Development timeline for Xenazine
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.